Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
59.81
+0.64 (1.08%)
At close: Aug 10, 2026, 4:00 PM EDT
59.93
+0.12 (0.20%)
Pre-market: Aug 11, 2026, 4:40 AM EDT

Moderna Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,2281,9443,2366,84819,26318,471
Revenue Growth
-27.62%-39.93%-52.74%-64.45%4.29%2200.25%
Gross Profit
5211,0761,7722,15513,84715,854
Operating Income
-3,320-3,074-3,945-4,2399,42013,296
Net Income
-3,151-2,822-3,561-4,7148,36212,202
Earnings Per Share
-7.99-7.26-9.28-12.3320.1228.29
EPS Growth
-----28.88%-

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Product Sales
2,0641,8183,1096,67118,43517,675
Grant
-223794388735
Collaboration
2813488344061
Licensing and Royalty
-1142---
Stand-Ready Manufacturing
11480----
Revenue (Total)
2,2281,9443,2366,84819,26318,471

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,1385,7997,0258,6049,90210,727
Total Debt
1,2351,2637101,2181,004705
Net Cash (Debt)
3,9034,5366,3157,3868,89810,022
Net Cash Growth
-11.96%-28.17%-14.50%-16.99%-11.21%127.72%
Net Cash Per Share
9.9111.6616.4519.3421.3923.25

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,073-1,873-3,004-3,1184,98113,620
Capital Expenditures
-171-192-1,051-707-400-284
Free Cash Flow
-1,244-2,065-4,055-3,8254,58113,336
Free Cash Flow Growth
-----65.65%580.75%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
23.38%55.35%54.76%31.47%71.88%85.83%
Operating Margin
-149.01%-158.13%-121.91%-61.90%48.90%71.98%
Pretax Margin
-138.55%-142.39%-111.46%-57.56%49.71%71.92%
Profit Margin
-141.43%-145.17%-110.04%-68.84%43.41%66.06%
FCF Margin
-55.83%-106.22%-125.31%-55.86%23.78%72.20%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----8.938.98
Forward PE
-31.9431.9431.9437.048.08
P/FCF Ratio
----15.107.68
PS Ratio
10.725.984.965.553.595.54